# US 2006/0078579 A1 · Organo-gel formulations for therapeutic applications

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0078579 A1
- Document ID: US20060078579A1
- Status: Published application
- Kind: A1
- Application number: 11/066,485
- Filed: 2005-02-28
- Published: 2006-04-13
- Earliest claimed: 2004-10-08
- Assignees: MediQuest Therapeutics, Inc.
- Inventors: Frederick Dechow
- Web page: https://patentgrep.com/patent/US20060078579A1

## CPC

- A61K 8/37: Esters of carboxylic acids
- A61K 8/042: {Gels}
- A61K 8/345: {containing more than one hydroxy group}
- A61K 8/42: Amides
- A61K 8/466: {containing sulfonic acid derivatives; Salts}
- A61K 8/553: {Phospholipids, e.g. lecithin}
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61K 47/24: containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A61P 17/00: Drugs for dermatological disorders
- A61P 31/10: Antimycotics
- A61Q 19/00: Preparations for care of the skin
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

A composition suitable for the local delivery of cosmetic and/or pharmaceutical agents into the skin containing at least two biocompatible organic solvents, a polar lipid, a surfactant, water, urea and a thickener wherein the organic solvents include an ester and a dihydric and/or polyhydric alcohol is provided. Also disclosed are compositions that further contain a cosmetic and/or pharmaceutical agent, along with the preparation and use thereof.

## Claims

### Claim 1

A composition suitable for the delivery of at least one cosmetic agent or pharmaceutical agent or both through the skin of a mammal, which comprises two biocompatible organic solvents, a polar lipid, at least one or more surfactant, water, urea and thickener; wherein the organic solvents comprise an ester and a dihydric alcohol and/or polyhydric alcohol; and wherein the composition comprises about 2 to about 30% of the ester and about 2 to about 20% of the dihydric alcohol and/or polyhydric alcohol.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the ester is a fatty monoester.

### Claim 3 (depends on 2)

The composition of claim 2, wherein the ester is obtainable by replacing the active hydrogen of a fatty acid having 4 to 22 carbon atoms by the alkyl group of a monohydric alcohol having 2 to about 8 carbon atoms.

### Claim 4 (depends on 2)

The compositions of claim 2, wherein the ester is an isopropyl ester.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the ester is at least one of isopropyl myristate or isopropyl palmitate.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the ester is isopropyl myristate.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the dihydric or polyhydric alcohol is an alkane alcohol and contains 3 to 8 carbon atoms.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6)

The composition of anyone of claims 1-6, wherein the alcohol is at least one of propylene glycol or glycerol.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6)

The composition of anyone of claims 1-6, wherein the alcohol is propylene glycol.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the polar lipid is at least one of lecithin or phosphalidylcholine.

### Claim 11 (depends on 1)

The composition of claim 1, wherein at least one surfactant is selected from the group consisting of docusate sodium, docusate sodium benzoate, docusate calcium, tetradecyltrimethylammonium bromide, pentaoxyethylene glycol monododecyl ether, and triethanolamine laureth sulfate.

### Claim 12 (depends on 2)

The composition according to claim 2, wherein the thickener is selected from the group of polyethylene glycol, methyl cellulose, and carbomer.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the amount of the polar lipid is about 10 to about 30% by weight; the amount of the surfactant is about 0.5 to about 15% by weight, the amount of water is about 40 to about 65% by weight, the amount of which is about 1 to about 15% by weight and amount of the thickener is about 0.05 to about 5% of weight.

### Claim 14 (depends on 1)

The composition of claim 1, wherein further certain at least one of a cosmetic agent or pharmaceutical agent or both.

### Claim 15 (depends on 14)

The composition of claim 14, wherein the amount of the cosmetic agent or pharmaceutical agent or both is about 0.001 to about 30% by weight.

### Claim 16 (depends on 14)

The composition of claim 14, having a pH of about 5.5 to about 7.5.

### Claim 17 (depends on 16)

The composition of claim 16, wherein the pH is about 6 to about 7.

### Claim 18 (depends on 1)

The composition of claim 1, further comprising at least 0.2-1.8% of a vasodilating agent.

### Claim 19 (depends on 18)

The composition of claim 18, wherein the vasodilating agent is glyceryl trinitrate.

### Claim 20 (depends on 1)

The composition, according to claim 1, further comprising about 1 to about 12% of an antimicrobial agent.

### Claim 21 (depends on 20)

The composition of claim 20, wherein the antimicrobial agent is selected from the group consisting of ciclopirox, miconazole, itraconazole, metronidazole, and allylamine and mixtures thereof and pharmaceutically acceptable salts thereof.

### Claim 22 (depends on 20)

The composition of claim 20, wherein the antimicrobial agent is selected from the group consisting of ciclopirox, miconazole, terbinafine and naftifine and mixtures thereof and salts thereof.

### Claim 23 (depends on 1)

The composition of claim 1, further comprising about 0.001-10.0% of an inhibitor of cell growth or proliferation.

### Claim 24 (depends on 23)

The composition of claim 23, wherein said inhibitor is 2-deoxy-D-glucose.

### Claim 25 (depends on 1)

The composition, according to claim 1, further comprising about 0.001-5.0% of an inhibitor of polyamine transport or 0.005-5.0% of an inhibitor of polyamine synthesis.

### Claim 26 (depends on 1)

The composition, according to claim 1, further comprising about 0.001-5.0% of an antizyme inducer.

### Claim 27 (depends on 1)

The composition, according to claim 1, further comprising about 0.5-10% of a decalcifying skin agent.

### Claim 28 (depends on 27)

The composition of claim 27, wherein the decalcifying skin agent is lactic acid.

### Claim 29 (depends on 1)

The composition, according to claim 1, further comprising at least two active ingredients.

### Claim 30 (depends on 14)

A method of delivering an active agent into and through the epidermis tissue of a human or animal which comprises topically applying to the skin of the human or animal a composition according to claim 14.

### Claim 31

A method of making a composition suitable for cutaneous delivery of a pharmaceutically active substance which comprises:
a. Dissolving a polar lipid, at least in two biocompatible organic solvents comprising at least one ester and at least one dihydric or polyhydric active;
b. Adding one or more surfactants to the composition of step (a);
c. Dissolving a pharmaceutically active compound in the solvent-polar lipid, surfactant mixture of step (b);
d. Adding urea and a thickener to water; and
e. Combining the composition from c and d and adjusting the pH to about 5.5 to about 7.5, if necessary.

### Claim 32 (depends on 31)

A composition prepared according to the method of claim 31.
